Glutamatergic neurometabolites during early abstinence from chronic methamphetamine abuse

International Journal of Neuropsychopharmacology

Volumn 18, Issue 3, 2015, Pages

  O'Neill, Joseph ^a   Tobias, Marc C ^a   Hudkins, Matthew ^a   London, Edythe D ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Semel Institute for Neuroscience ^*  (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Abstinence; Depression; Glutamate; Magnetic resonance spectroscopy; Methamphetamine

Indexed keywords

GLUTAMIC ACID; GLUTAMINE; METHAMPHETAMINE; PROTON;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; FEMALE; HOSPITAL PATIENT; HUMAN; INFERIOR FRONTAL GYRUS; MALE; METHAMPHETAMINE DEPENDENCE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSTERIOR CINGULATE; PRECUNEUS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SMOKING; WITHDRAWAL SYNDROME; AMPHETAMINE DEPENDENCE; BRAIN; CASE CONTROL STUDY; DRUG DEPENDENCE; IMAGE PROCESSING; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; STATISTICS; YOUNG ADULT;

ADULT; AMPHETAMINE-RELATED DISORDERS; BRAIN; CASE-CONTROL STUDIES; FEMALE; GLUTAMIC ACID; GLUTAMINE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROTONS; STATISTICS AS TOPIC; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 85005900828     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyu059     Document Type: Article

References (58)

1. Aron AR, Robbins TW, Poldrack RA (2014) Inhibition and the right inferior frontal cortex: one decade on. Trends Cogn Sci 18:177-185
2. Baicy K, London ED (2007) Corticolimbic dysregulation and chronic methamphetamine abuse. Addiction 102(Suppl 1):5-15.
3. Beck AT, Steer RA, Ball R, Ranieri W (1996) Comparison of Beck Depression Inventories-IA and-II in psychiatric outpatients. J Person Assess 67:588-97.
4. Berman SM, Voytek B, Mandelkern MA, Hassid D, Isaacson A, Monterosso J, Miotto K, Ling W, London ED (2008). Changes in regional cerebral metabolism during early abstinence from chronic methamphetamine abuse. Molec Psychiatry 13:897-908.
5. Blanton RE, Levitt JG, Peterson JR, Fadale D, Sporty ML, Lee M, To D, Mormino EC, Thompson PM, McCracken JT, Toga AW (2004) Gender differences in the left inferior frontal gyrus in normal children. NeuroImage 22:626-636.
6. Brecht ML, von Mayrhauser C, Anglin MD (2000) Predictors of relapse after treatment for methamphetamine use. J Psycho-active Drugs 32:211-220.
7. Carroll FI (2008) Antagonists at metabotropic glutamate receptor subtype 5: structure activity relationships and therapeutic potential for addiction. Ann NYAS 1141:221-232.
8. Chang L, Ernst T, Speck O, Grob CS (2005) Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. Am J Psychiatry 114:65-79.
9. Cloak CC, Alicata D, Chang L, Andrews-Shigaki B, Ernst T (2011) Age and sex effects of choline compounds in the anterior cin-gulate cortex of adolescent methamphetamine users. Drug Alcohol Depend 119:207-215.
10. Commins DL, Seiden LS (1986) Alpha-methyltyrosine blocks methylamphetamine-induced degeneration in the rat soma-tosensory cortex. Brain Res 365:15-20
11. Davidson RJ (1992) Emotion and affective style: hemispheric substrates. Psych Sci 3:39-43.
12. Descarries L, Lemay B, Doucet G, Berger B (1987) Regional and laminar density of the dopamine innervation in adult rat cerebral cortex. Neurosci 21:807-824.
13. Eisch AJ, O'Dell SJ, Marshall JF (1996) Striatal and cortical NMDA receptors are altered by a neurotoxic regimen of metham-phetamine. Synapse 22:217-225
14. Elkashef AM, Rawson RA, Anderson AL, Li S-H, Holmes T, Smith EV, Chiang N, Kahn R, Vocci F, Ling W, Pearce VJ, McCann M, Campbell J, Gorodetzky C, Haning W, Carlton B, Mawhinney J, Weis D (2007) Bupropion for the treatment of methampheta-mine dependence. Neuropsychopharmacology 33:1162-1170.
15. Ernst T, Chang L (2008) Adaptation of brain glutamate plus glu-tamine during abstinence from chronic methamphetamine use. J Neuroimmun Pharmacol 3:165-172.
16. Ernst T, Chang L, Leonido-Yee M, Speck O (2000) Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study. Neurology 54:1344-1349.
17. Goldstein K (1939) The organism. New York: American Books.
18. Gonzales R, Mooney L, Rawson RA (2010) The methampheta-mine problem in the United States. Annu Rev Public Health 31:385-398.
19. Hellige JB (1993) Hemispheric asymmetry. Cambridge, MA: Harvard University Press.
20. 1H-MRS) in methamphetamine dependence and meth-amphetamine induced psychosis. Schiz Res 153:122-128.
21. Iijima M, Koike H, Chaki S (2013) Effect of an mGlu2/3 receptor antagonist on depressive behavior induced by withdrawal from chronic treatment with methamphetamine. Behav Brain Res 246:24-28.
22. Kaushal N, Matsumoto RR (2011) Role of sigma receptors in methamphetamine-induced neurotoxicity. Curr Neurophar-macol 9:54-57.
23. Kim I-S, Kim Y-T, Song H-J, Lee J-J, Kwon D-H, Lee HJ, Kim M-N, Yoo D-S, Chang Y (2009) Reduced corpus callosum white matter microstructural integrity revealed by diffusion tensor eigenvalues in abstinent methamphetamine addicts. Neuro-toxicol 30:209-213.
24. Kim SJ, Lyoo IK, Hwang J, Chung A, Sung YH, Kim J, Kwon D-H, Chang KH, Renshaw PF (2005) Prefrontal grey-matter changes in short-term and long-term abstinent methamphetamine abusers. Int J Neuropsychopharmacol 8:1-8.
25. London ED, Simon S, Berman SM, Mandelkern MA, Lichtman AM, Bramen J, Shinn AK, Miotto K, Learn J, Dong Y, Matochik JA, Kurian V, Newton T, Woods R, Rawson R, Ling W (2004) Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry 61:73-84.
26. Monterosso JR, Aron AR, Cordova X, Xu J, London ED (2005) Def-cits in response inhibition associated with chronic metham-phetamine abuse. Drug Alcohol Depend 79:273-277.
27. Morales A, Lee B, Hellemann G, O'Neill J, London ED (2012) Gray-matter volume in methamphetamine dependence: cigarette smoking and changes with abstinence from methampheta-mine. Drug Alcohol Depend 125:230-238.
28. Newton TF, Kalechstein AD, Duran S, Vansluis N, Ling W (2004) Methamphetamine abstinence syndrome: preliminary fnd-ings. Am J Addiction 13:248-255.
29. Nordahl TE, Salo R, Possin K, Gibson DR, Flynn N, Leamon M, Galloway GP, Pfefferbaum A, Spielman DM, Adalsteinsson E, Sullivan E (2002) Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: a preliminary proton MRS study. Psychiatry Res Neuroimaging 116:43-52.
30. Nordahl TE, Salo R, Natsuaki Y, Galloway GP, Waters C, Moore CD, Kile S, Buonocore MH (2005) Methamphetamine users in sustained abstinence: a proton magnetic resonance spectros-copy study. Arch Gen Psychiatry 62:444-452.
31. O'Neill J, Sobel TL, Vogt BA (2009) Localizing cingulate subre-gions-of-interest in magnetic resonance images guided by cytological parcellations. In: Cingulate neurobiology and disease (Vogt BA, ed), pp 587-617. Oxford: Oxford University Press.
32. O'Neill J, Tobias M, Hudkins M, Oh E, Hellemann G, Nurmi E, London ED (2014) Thalamic glutamate decreases with cigarette smoking. Psychopharmacology (Berl) 231:2717-2724.
33. Pu C, Broening HW, Vorhees CV (1996) Effect of methampheta-mine on glutamate-positive neurons in the adult and developing rat somatosensory cortex. Synapse 23:328-334.
34. Rawson RA, Marinelli-Casey P, Anglin MD, Dickow A, Frazier Y, Gallagher C, Galloway GP, Herrell J, Huber A, McCann MJ, Obert J, Pennell S, Reiber C, Vandersloot D, Zweben J, Meth-amphetamine Treatment Project Cooperative Authors (2004) A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction 99:708-717.
35. Ryan LJ, Linder JC, Martone ME, Groves PM (1990) Histological and ultrastructural evidence that D-amphetamine causes degeneration in neostriatum and frontal cortex of rats. Brain Res 518:67-77.
36. Sailasuta N, Abulseoud O, Hernandez M, Haghani P, Ross BD (2010) Metabolic abnormalities in abstinent methampheta-mine dependent subjects. Subst Abuse 2010:9-20.
37. Salo R, Nordahl TE, Natsuaki Y, Leamon MH, Galloway GP, Waters C, Moore CD, Buonocore MH (2007) Attentional control and brain metabolite levels in methamphetamine abusers. Biol Psychiatry 61:1272-1280.
38. Salo R, Buononcore MH, Leamon M, Natsuaki Y, Waters C, Moore CD, Galloway GP, Nordahl TE (2011a) Extended fndings of brain metabolite normalization in MA-dependent subjects across sustained abstinence: a proton MRS study. Drug Alcohol Depend 113:133-138.
39. Salo R, Nordahl TE, Buononcore MH, Natsuaki YT, Moore CD, Waters C, Leamon MH (2011b) Spatial inhibition and the visual cortex: a magnetic resonance spectroscopy imaging study. Neuropsychologia 49:830-838.
40. Sanacora G, Treccani G, Popoli M (2011) Towards a glutamate hypothesis of depression: an emerging frontier of neuropsy-chopharmacology for mood disorders. Neuropharmacol 62:63-77.
41. Seese RR, O'Neill J, Hudkins M, Siddarth P, Levitt J, Tseng B, Wu KN, Caplan R (2011) Proton magnetic resonance spectroscopy and thought disorder in childhood schizophrenia. Schiz Res 133:82-90.
42. Sekine Y, Minabe Y, Kawai M, Suzuki K, Iyo M, Isoda H, Sakahara K, Ashby CR Jr, Takei N, Mori N (2002) Metabolite alterations in basal ganglia associated with methamphetamine-related psychiatric symptoms: a proton MRS study. Neuropsychophar-macol 27:453-461.
43. Shoptaw SJ, Kao U, Heinzerling K, Ling W (2009) Treatment for amphetamine withdrawal. Cochrane Database Syst Rev 2:1-27.
44. Sibson NR, Shen J, Mason GF, Rothman DL, Behar KL, Shulman RG (1998) Functional energy metabolism: in vivo 13C-NMR spectroscopy evidence for coupling of cerebral glucose consumption and glutamatergic neuronal activity. Devel Neurosci 20:321-330.
45. 123I]TPCNE-A novel SPET tracer for the sigma-1 receptor: frst human studies and in vivo haloperidol challenge. Synapse 60:109-117.
46. Swick D, Ashley V, Turken AU (2008) Left inferior frontal gyrus is critical for response inhibition. BMC Neurosci 9:102.
47. Sung YH, Cho SC, Hwang J, Kim SJ, Kim H, Bae S, Kim N, Chang KH, Daniels M, Renshaw PF, Lyoo IK (2007) Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study. Drug Alcohol Depend 88:28-35.
48. Tabibnia G, Monterosso JR, Baicy K, Aron AR, Poldrack RA, Chakra-pani S, Lee B, London ED (2011) Different forms of self-control share a neurocognitive substrate. J Neurosci 31:4805-4810.
49. Taylor MJ, Schweinsburg BC, Alhassoon OM, Gongvatana A, Brown GG, Young-Casey C, Letendre SL, Grant I, HNRC Group (2007) Effects of human immunodefciency virus and methamphetamine on cerebral metabolites measured with magnetic resonance spectroscopy. J Neurovirol 13:150-159.
50. Thompson PM, Hayashi K, Simon SL, Geaga JA, Hong MS, Sui Y, Lee JY, Toga AW, Ling W, London ED (2004) Structural abnormalities in the brains of human subjects who use metham-phetamine. J Neurosci 24:6028-6036.
51. Tobias MC, O'Neill J, Hudkins M, Bartzokis G, Dean AC, London ED (2010) White-matter abnormalities in brain during early abstinence from methamphetamine abuse. Psychopharmacol 209:13-24.
52. Tucker DM (1987) Hemisphere specialization: a mechanism for unifying anterior and posterior brain regions. In: Duality and unity of the brain (Ottoson D, ed). London: MacMillan Press.
53. Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Wong C, Logan J (2001) Higher cortical and lower subcortical metabolism in detoxi-fed methamphetamine abusers. Am J Psychiatry 158:383-389.
54. 1H MR spectroscopy study. Addict Biol doi:10.1111/adb.12078.
55. Zachary RA, Paulson MJ, Gorsuch RL (1985) Estimating WAIS IQ from the Shipley Institute of Living Scale using continuously adjusted age norms. J Clin Psychol 41:820-831.
56. Zarate C, Duman RS, Liu G, Sartori S, Quiroz J, Murck H (2013) New paradigms for treatment-resistant depression. Ann NYAS 1292:21-31.
57. Zorick T, Nestor L, Miotto K, Sugar C, Hellemann G, Scanlon G, Rawson R, London ED (2010) Withdrawal symptoms in abstinent methamphetamine-dependent subjects. Addiction 105:1809-1818.
58. Zorick T, Sugar C, Hellemann G, Shoptaw S, London ED (2011) Poor response to sertraline in methamphetamine dependence is associated with sustained craving for methampheta-mine. Drug Alcohol Depend 118:500-503.